Lifecore Biomedical
LFCR
LFCR
94 hedge funds and large institutions have $376M invested in Lifecore Biomedical in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
19% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 27
9% more funds holding
Funds holding: 86 → 94 (+8)
0.67% more ownership
Funds ownership: 92.04% → 92.71% (+0.67%)
Holders
94
Holding in Top 10
2
Calls
$488K
Puts
$1K
Top Buyers
| 1 | +$2.9M | |
| 2 | +$2.62M | |
| 3 | +$2.01M | |
| 4 |
Two Sigma Investments
New York
|
+$771K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$573K |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$2.16M | |
| 3 | -$1.59M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$1.08M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$876K |